Literature DB >> 3552013

Drug-targeting by monoclonal antibodies.

M J Embleton.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3552013      PMCID： PMC2001752          DOI： 10.1038/bjc.1987.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  19 in total

1.  Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage.

Authors:  G F Rowland; G J O'Neill; D A Davies
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

2.  Tumor therapy with monoclonal antibodies.

Authors:  R Levy; R A Miller
Journal:  Fed Proc       Date:  1983-06

3.  Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.

Authors:  L Winger; C Winger; P Shastry; A Russell; M Longenecker
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 4.  The preparation and cytotoxic properties of antibody-toxin conjugates.

Authors:  P E Thorpe; W C Ross
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells.

Authors:  K Eiklid; S Olsnes; A Pihl
Journal:  Exp Cell Res       Date:  1980-04       Impact factor: 3.905

6.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

7.  Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.

Authors:  D M Herlyn; Z Steplewski; M F Herlyn; H Koprowski
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

8.  Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

Authors:  H Koprowski; D Herlyn; M Lubeck; E DeFreitas; H F Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

Authors:  J Ritz; J M Pesando; S E Sallan; L A Clavell; J Notis-McConarty; P Rosenthal; S F Schlossman
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

10.  Antibody-guided irradiation of malignant pleural and pericardial effusions.

Authors:  D Pectasides; S Stewart; N Courtenay-Luck; R Rampling; A J Munro; T Krausz; B Dhokia; D Snook; G Hooker; H Durbin
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640
View more
  3 in total

Review 1.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

Review 2.  Systemic immunotoxin therapy of cancer: advances and prospects.

Authors:  E J Wawrzynczak
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

3.  Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.

Authors:  K Takashina; K Kitamura; T Yamaguchi; A Noguchi; A Noguchi; H Tsurumi; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1991-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.